Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FutureChemistry is a Netherlands-based technology provider and boutique consultancy specializing in continuous flow chemistry and radiopharmaceutical process development. Founded in 2007 as a spin-off from Radboud University Nijmegen and the Fraunhofer Institute IMS, the company helps translate radiochemistry into robust, automated, and GMP-compliant production processes. FutureChemistry designs and engineers specialized microreactor systems, such as the FlowSafe and FlowStart Evo platforms, to optimize chemical reactions and automate the synthesis of PET tracers and other radiopharmaceuticals. The company operates strictly as a service and technology provider, choosing not to develop its own therapeutic candidates or claim customer intellectual property.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FutureChemistry.